Report: ‘Convergence Science’ Has Potential To Accelerate The Research-To-Product Pipeline
Some say this trend is the future of biomedical research. But along with its potential, it also faces significant challenges.
Cancer
221-238 of 238 results
-
-
End-Of-Life Care Better For Patients With Cancer, Dementia: Study Finds
Researchers concluded that physicians and other health professionals are less likely to know or accommodate the advanced-care preferences of patients with conditions such as renal disease or congestive heart failure, among others.
-
Colon Cancer Screening: Five Things To Know
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
-
Harmful Chemicals Are Everywhere — But What Does That Mean?
A report by the Environmental Working Group measures how much Americans are exposed to a variety of chemicals that may be linked to cancer.
By Zhai Yun Tan -
People With HIV Are Less Likely To Get Cancer Treatment
New research finds that patients infected with the virus that causes AIDS are less likely to get treatment for nine common cancers than are people who don’t have HIV.
-
More Exchange Plans Offer Patients Easier Access To Some Expensive Drugs: Report
The analysis by Avalere examines changes in how silver plans on the insurance marketplaces handle coverage for high-cost specialty drugs.
-
Genetic Counselors Struggle To Keep Up With Huge New Demand
After Angelina Jolie disclosed her genetic predisposition for breast cancer, demand for genetic tests went up. Counselors help interpret those tests, and demand for their services has increased, too.
-
Rise In Oncologists Working For Hospitals Spurs Higher Chemo Costs: Study
Researchers found that the facility fees hospitals and their clinics routinely add to the bill helps drive the price increases.
-
Mortgages For Expensive Health Care? Some Experts Think It Can Work.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
-
For Terminally Ill In California, End Of Suffering Is Now In Sight
Terminal patients and doctors prepare themselves for California’s new assisted suicide law, which takes effect June 9.
By Anna Gorman -
Insurer’s Approval Of Genetic Testing For Some Cancers Raises Questions
The decision by Independence Blue Cross of Pennsylvania to pay for whole genome sequencing for some cancer patients adds to the debate about how to handle these expensive tests.
-
Consumer And Research Groups Release Cancer Guides For Patients
Families USA and the Institute for Clinical and Economic Review are collaborating on a series of patient guides on treatment and screenings.
-
Heavy Use Of CT Scans Raises Concerns About Patients’ Exposure To Radiation
CT scans, which are administered more than 85 million times a year, are an important diagnostic tool, but just one can be equivalent to 200 X-rays. Some doctors warn that health providers are not considering possible consequences when ordering the tests.
-
More Employers Offer Plans That Provide Lump Sums For Critical Illnesses
The plans can help workers cover their high deductibles, but the policies also have limitations.
-
Medicare Payment Changes Lead More Men To Get Screening Colonoscopies
The health law waived Medicare’s Part B deductible and dropped the 20 percent copayment for the preventive tests.
-
Health Plans’ Coverage Of Some Drugs Can Be A Source Of Consumer Confusion
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
-
Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
-
Calif. Medicaid Patients With Cancer Fare Worse Than Those With Other Coverage
Researchers found Medi-Cal patients were diagnosed later, were less likely to receive recommended treatment and had lower survival rates.
Ìý